THE INVISIBLE FACE MASK

Serial Number 79298645
Registration 6557445
700

Registration Progress

Application Filed
Sep 28, 2020
Under Examination
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered
Nov 16, 2021

Trademark Image

THE INVISIBLE FACE MASK

Basic Information

Serial Number
79298645
Registration Number
6557445
Filing Date
September 28, 2020
Registration Date
November 16, 2021
Published for Opposition
April 13, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 16, 2021
Registration
Registered
Classes
005

Rights Holder

JNTL Consumer Health I (Switzerland) GmbH

27
Address
Gubelstrasse 34
CH-6300 Zug
CH

Ownership History

Nasaleze Patents Limited

Original Applicant
99
GB

Nasaleze Patents Limited

Owner at Publication
99
GB

Nasaleze Patents Limited

Original Registrant
99
GB

JNTL Consumer Health I (Switzerland) GmbH

New Owner After Registration #1
27
CH

Legal Representation

Attorney
Matthew Pater

USPTO Deadlines

Next Deadline
833 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-11-16)
Due Date
November 16, 2027
Grace Period Ends
May 16, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Sep 19, 2024 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Sep 9, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 9, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 9, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 9, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 9, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 9, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 30, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 6, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 5, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 16, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 6, 2021 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
May 12, 2021 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Apr 13, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 24, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 22, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 8, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 3, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 2, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 2, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 26, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 26, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 12, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 11, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 4, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 26, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Biological preparations for medical purposes for the treatment of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease; bronchodilatory preparations; cellulose ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; chemical preparations for medical purposes, namely, for the treatment of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease; chemical preparations for pharmaceutical purposes all for use in the treatment, relief and prevention of hay fever, asthma, eczema, allergies, viral disease and aerial pollution-related disease

Classification

International Classes
005